CapMan Hotels RE Ky fund sells 100% of its ownership in the Rantasipi Sveitsi hotel property based in Hyvinkää, Finland to Sveitsi Kiinteistörahasto Ky, which is owned by a consortium of investors established to develop the hotel. The transaction was completed on 20 September 2016.

Restel’s lease of the property came to an end in spring 2016. The new owner will convert the hotel property into a versatile centre for active travel and leisure suitable for both conference guests and families. In addition, the city of Hyvinkää and the new owner have agreed to expand the existing public swimming pool in Hyvinkää into a spa-like facility. 

“The timing to sell the asset is most convenient from the fund’s perspective, as the lease has recently expired. We are very pleased that we have found an energetic new owner for Rantasipi Sveitsi, who is committed to developing this hotel and revitalising it to its full splendour, taking its colourful history into account. We believe that the project will have a positive effect on the city of Hyvinkää by increasing the attractiveness of the area,” comments Pirjo Ojanperä, Partner of CapMan Real Estate.

CapMan Hotels RE Ky fund was established in 2008 and it manages 39 hotel properties in Finland and Sweden. The fund includes, among others, the hotel properties of Crowne Plaza and GLO Hotel Art in central Helsinki.

For additional information, please contact:
Pirjo Ojanperä, Partner, CapMan Real Estate, tel. +358 50 388 3306

CapMan www.capman.com

CapMan is a leading Nordic investment and asset management company. For more than 25 years, we have been developing companies and real estate and supporting their sustainable growth. We are committed to understanding the needs of our customers in an ever-changing market environment. Our objective is to provide attractive returns and innovative solutions for our investors and value adding services for professional investment partnerships, growth-oriented companies and tenants. Our independent investment partnerships – Buyout, Real Estate, Russia and Nest Capital – as well as our associated company Norvestia are responsible for investment activities and value creation. CapMan’s service business offering includes fundraising advisory services, purchasing activities and fund management services to both internal and external customers. CapMan has 100 professionals and assets under management of €2.8 billion.

Gimv provides EUR 30 million of growth equity to fast-growing medical device company Spineart

Spineart today announces that it secured a EUR 30 million investment from Gimv[1], which thus becomes an important shareholder in the company. These proceeds will be used to reinforce the company’s sales organization and processes, for further geographical expansion in selective markets such as the US, as well as for continued development of innovative and disruptive products.

Spineart (www.spineart.com) is a fast-growing Swiss medical device company focused on simplifying spinal surgery by designing, developing and promoting safe and efficient solutions to surgeons, operating room teams and patients. Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of motion preservation, fusion, biologics, minimally invasive surgery and fractures treatment. Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus promoting greater safety, cost-efficiency, and compliance at the hospital. On top it offers strong customer service as well as high-quality training to physicians.

The company was co-founded in 2005 by Jérome Levieux and Stéphane Mugnier-Jacob, who both have over 20 years’ experience in the spine industry and co-lead Spineart. Over the past five years, Spineart grew by 16% on a yearly basis to reach a worldwide turnover of EUR 34 million in 2015. The goal for the coming years is to continue and further accelerate its expansion, by growing its market share in Europe and the US as well as by entering new markets. The company currently employs about 100 FTEs.

“Gimv is the partner we need to reach the next level. Its Health & Care team’s experience in accompanying fast growing companies will help to reach Spineart’s ambitious goals. Therefore, we are very pleased to have them on board and are excited to write together the next chapter in Spineart’s history,” said Jérôme Levieux and Stéphane Mugnier-Jabob, co-founders and co-CEOs of Spineart.

Peter Byloos, Partner in Gimv’s Health & Care team, comments: “Spine surgery is an attractive global market offering plenty of room for challengers such as Spineart. Next to its broad product portfolio and recognized European brand, the company differentiates itself by a strong focus on product innovation and full R&D pipeline. We look forward to share our expertise in the field of Building Companies and International Operations with Spineart’s experienced and committed leadership team. After EndoStim (US-NL), G-Therapeutics (CH) and Topas Therapeutics (GE) this is the fourth new investment of our Health & Care platform since the beginning of the year.”

[1] Joint-investment by Gimv and the Gimv Health & Care Fund

2016-09-16 17:31 GMT+02

Kinnevik AB (publ) (“Kinnevik”) today published financial results for the first six months 2016 for Global Fashion Group (including the regional businesses Lamoda, Dafiti, Namshi and Zalora). 

Global Fashion Group will host a conference call today, 15 September 2016, at 10.00 CET to present the results for the first six months 2016. Participants are welcome to join by phone using the below dial-in details:

DE: +49 (0) 69 2222 10633
UK: +44 (0) 20 3427 1924
USA: +1 646 254 3387
SE: +46 (0) 8 506 539 34

PIN Code: 9689105#

Summary financials for Global Fashion Group (including Lamoda, Dafiti, Namshi and Zalora) can be found on the following pages of this press release.

For further information, visit www.kinnevik.com or contact:

Egeria, the Dutch based private equity firm has signed an agreement to acquire 100% of the shares of Clondalkin Flexible Packaging Group (“Clondalkin”) from an affiliate of Warburg Pincus. Completion of the transaction is expected to occur in Q4 2016. Clondalkin Flexible Packaging Group (“Clondalkin”) is a global flexible packaging manufacturer focused on delivering high quality innovative packaging solutions. Clondalkin comprises 11 manufacturing sites in The Netherlands, Germany, Switzerland, United Kingdom and USA supplying over 45 countries globally with a turnover of approximately €400 million.

Egeria has a proven track record in growing and developing international manufacturing businesses both organically and through acquisitions.  Paddy Mullaney, CEO of Clondalkin said “We are delighted to team up with Egeria for the next step of our development plan. Egeria’s experience in supporting businesses will further facilitate and strengthen Clondalkin’s continued development and expansion.”   Floris Waage, partner at Egeria, commented: “We are very excited to team up with Clondalkin. The company has a long history of delivering high value added products and putting its customers first. We are committed to supporting Clondalkin and are convinced it has attractive growth opportunities.”